Drug archive
Alfuzosin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Benign prostatic hyperplasia therapy agent
Description
Alfuzosin((al-FYOO-zoe-sin)) is used to treat the signs and symptoms of benign enlargement of the prostate (benign prostatic hyperplasia or BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. As the prostate gland enlarges, certain muscles in the gland may become tight and get in the way of the tube that drains urine from the bladder. This can cause problems in urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely. Alfuzosin helps relax the muscles in the prostate and the opening of the bladder. This may help increase the flow of urine and/or decrease the symptoms.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Tablets (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Uroxatral;
In Canada -
- Xatral